Genenta Science
GNTA
5 hedge funds and large institutions have $2.1M invested in Genenta Science in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
48% more capital invested
Capital invested by funds: $1.42M → $2.1M (+$680K)
25% more funds holding
Funds holding: 4 → 5 (+1)
0.97% more ownership
Funds ownership: 1.97% → 2.94% (+0.97%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
A
Allianz
Munich,
Germany
|
+$524K |
| 2 |
AU
Algebris (UK)
London,
United Kingdom
|
+$221K |
| 3 |
Morgan Stanley
New York
|
+$13.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$366 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$46.5K |
GNTA Hedge Fund Activity: Q1 2025 in Review
5 of the 7,473 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q1 2025, worth a combined $2.1M — up 48% from $1.42M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GNTA positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Allianz, adding an estimated $524K. The largest seller was Citadel Advisors, exiting entirely with an estimated $46.5K sold.
- 5 institutional investors held Genenta Science (GNTA) as of Q1 2025, up from 4 in Q4 2024.
- Funds reported $2.1M of Genenta Science stock for Q1 2025, up 48% quarter-over-quarter.
- 2 funds opened new Genenta Science positions in Q1 2025 and 1 closed out, a net change of +1 holder.
- The largest Genenta Science buyer in Q1 2025 was Allianz, an estimated $524K added.
- The largest Genenta Science seller in Q1 2025 was Citadel Advisors, an estimated $46.5K sold.
Based on aggregated 13F filings for Q1 2025.